Menu
/REGISTER
Montecito
Tolman Wiker
Pac Premier
Farmers merchants
Loading...
You are here:  Home  >  Biotech  >  Current Article

Sientra shares soar as earnings beat expectations

By   /   Thursday, November 7th, 2019  /   No Comments

    Print       Email
Goleta breast implant developer Sientra announced plans to streamline its miraDry operations and acquire its Opus brand manufacturer from Lubrizol Life Science for $20 million in cash. In an accompanying earnings statement, the company also hiked up its guidance for the year after a quarter in which sales rose 33 percent and net losses beat…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

Leave a Reply

Your email address will not be published. Required fields are marked *

You might also like...

Apeel adding facilities in Mexico, Peru and Netherlands

Read More →